STOCK TITAN

1.6M-share sale filing — Roivant (NASDAQ: ROIV) insider plans sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Frank M. Torti filed a Form 144 disclosing an intended sale of 1,600,000 shares of common stock of the issuer ROIV on 02/20/2026 tied to an exercise of stock options. The filing shows an aggregate value of $44,032,000 and identifies Morgan Stanley Smith Barney LLC as broker.

The filing also records prior 10b5-1 sales by Mr. Torti of 1,400,000 shares on 02/19/2026 with proceeds of $38,392,834.26. Transaction mechanics are shown as cash proceeds from option exercise.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 records option exercise and a brokered sale of common shares.

The filing lists an intended disposal of 1,600,000 common shares on 02/20/2026 associated with an exercise of stock options, with an indicated aggregate amount of $44,032,000. A broker, Morgan Stanley Smith Barney LLC, is named for the transaction.

Prior 10b5-1 sales of 1,400,000 shares on 02/19/2026 produced $38,392,834.26. Timing and cash-flow mechanics are shown as cash from option exercise; subsequent filings will report completed trades and exact allocation of proceeds.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ROIV Form 144 disclose?

The Form 144 discloses an intended sale of 1,600,000 shares tied to an exercise of stock options on 02/20/2026, with an aggregate amount of $44,032,000 and a named broker.

Who is listed as the broker for the ROIV sale?

Morgan Stanley Smith Barney LLC is named as the broker for the transaction, with the filing linking the sale date to 02/20/2026 and the method identified as cash from option exercise.

Has the filer recently sold other ROIV shares?

Yes. The Form 144 records prior 10b5-1 sales by Frank M. Torti of 1,400,000 shares on 02/19/2026, generating $38,392,834.26 in proceeds.

Does the Form 144 state how proceeds will be used?

The filing ties the transaction to an exercise of stock options and lists cash as the consideration, but it does not specify uses of proceeds in the disclosed lines of the excerpt.
Roivant Sciences

NASDAQ:ROIV

ROIV Rankings

ROIV Latest News

ROIV Latest SEC Filings

ROIV Stock Data

19.70B
480.51M
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
LONDON